ACTO 2012 Scientific Program updated on Sep. 28

The 3rd Meeting of Asian Cellular Therapy Organization

November15-17, 2012, Le Méridien Chiangmai, Chiangmai, Thailand

Scientific Program

Date / Time / Convention Hall II & III
Thursday, November 15, 2012 / 14.00-15.00 / Corporate Symposium
Superior A.R.T.
15.00-15.30 / Coffee Break
15.30-16.30 / ACTO Committee Session
Chair: Weerasak Nawarawong, Mohiuddin Ahmed Khan
Development of cellular therapy in Japan: Business model proposal
Yoichi Takaue (Japan) (15 mins)
Current situation of hematopoietic stem cell transplantation in P.R China
Kaiyan Liu (P.R. China) (15 mins)
Treatment of hematological malignancies - in Bangladesh perspective
Mohiuddin Ahmed Khan (Bangladesh)(15 mins)
-TBA-
Mickey Koh (Singapore) (15 mins)
16.30-17.30 / Symposium I: Regenerative Medicine I
Chair: Udomsak Bunworasate, Douglas Sipp
1.1)  Cartilage repair with autologous bone marrow mesenchymal stem cell
Shigeyuki Wakitani (Japan)(30 mins)
1.2)  Carilage repair with allogeneic synovial mesenchymal stem cells expanded with
serum-free media
Yukio Kato (Japan) ( 30 mins)
Date / Time / Convention Hall II & III
Friday, November 16, 2012 / 08.30-10.00 / Symposium II: Hematopoietic stem cell
Chair: Saengsuree Jootar, Keiya Ozawa
2.1) Minimal residual disease in leukemia
Dario Campana (Singapore) (30 mins)
2.2)  Hematopoietic regulation and expansion
Daisuke Sugiyama (Japan )(30 mins)
2.3)  The result of mesenchymal stem cell trial for Treatment of GVHD treatment
Keiya Ozawa (Japan) (30 mins)
10.00-10.30 / Coffee Break
10.30-12.00 / Symposium III: Adoptive cellular immunotherapy
Chair: Tanin Intragumtornchai, Yoichi Takaue
3.1) Haploidenticalstem cell transplantation: newmethods for graft manipulation
Peter Lang (Germany)(30 mins)
3.2) NK cell therapy
Dario Campana (Singapore) (30 mins)
3.3) Use of virus specific T cells
Peter Lang (Germany)(30 mins)
12.00-13.30 / Luncheon Symposium
Lonza symposium
13.30-15.00 / Symposium IV: Embryonic and Mesenchymal stem cells and Reprogramming
Chair: Surapol Issaragrisil, Kaiyan Liu
4.1) Biology of embryonic stem cell
Peter Andrews (UK)(30 mins)
4.2) Biology of mesenchymal stem cell
Edwin Horwitz (USA)(30 mins)
4.3) Induced pluripotent stem cell (iPS)
Peter Andrews (UK)(30 mins)
15.00-15.30 / Coffee Break
15.30-17.10 / Joint ACTO & EBMT Session: Nuclear accident
Chair: Suradej Hongeng, Akihiro Shimosaka, Ray Powles
European Blood and Marrow Transplant EBMT Radiation Preparedness Network Session
Ray Powles (UK) (20 mins)
Nuclear accident: Situation in Japan
Shuichi Taniguchi (Japan) (20 mins)
Nuclear accident: Situation in P.R. China
Hu Chen (P.R. China)(20 mins)
Nuclear accident: Situation in Korea
Cho Minsu (Korea) (20 mins)
Cytoprotective potentials of human placenta-chorionic mesenchymal stromal cells: possible
role in the rescue of nuclear accident victims
Yao Chang Chen (Taiwan)(20 mins)
18.30-21.00 / Khan Tok Dinner at Khum Khan Tok
Date / Time / Convention Hall II & III
Saturday, November 17, 2012 / 08.30-10.00 / Symposium V: Regenerative medicine II
Chair: Wanchai Wanachiwanawin, Shinji Miyake
5.1) Liver stem cell and differentiation
Luc Gailhouste (Japan)(30 mins)
5.2)  Immortalized hepatocyte like cell from mesenchymal stem cell: application for disease model
Suradej Hongeng (Thailand)(30 mins)
5.3)  Modeling the hematological disorders with patient-specific induced pluripotent stem cells
Methichit Wattanapanitch (Thailand)(30 mins)
10.00-10.30 / Coffee Break
10.30-11.00 / Joint ACTO & ISCT Session
Chair: Panya Seksarn, Akihiro Shimosaka
Mesenchymal stem cell in metabolic bone diseases
Edwin Horwitz (USA)(30 mins)
11.00-12.00 / Symposium VI: Innovative modality
Chair: Panya Seksarn, Younjoo Park
6.1 Overview of cellular drugs in Japan.
Shinji Miyake (Japan) (20mins)
6.2 Advanced Medical Technology Review System in Japan
Kiyoshi Okada (Japan) (20mins)
6.3 Adipose derived stem cells: a potential target for cancer Immunotherapy
Abbas Ghaderi (Iran) (20mins)
12.00-13.30 / Lunch
13.30-15.00 / Symposium VII: Regulatory issue
Chair: Wichai Prayoonwiwat, Kellathur N. Srinivasan
7.1)  Regulatory issue in global stem cell research
Douglas Sipp (Japan)(15 mins)
7.2)  Regulatory issues of the cellular products
Koji Kawakami (Japan)(15 mins)
7.3)  Regulation of human cell-and tissue-based therapy in Singapore
Kellathur N. Srinivasan (Singapore) (15 mins)
7.4) Regulatory issue in EU
Maria Cristina Galli (Italy)(15 mins)
7.5) Regulatory issue in Korea
Younjoo Park (Korea)(15 mins)
15.00-15.30 / Coffee Break
15.30-17.00 / Symposium VIII: Gene therapy
Chair: Artit Ungkanont, Maria Cristina Galli
8.1) Gene therapy in Thalassemia
Philppe Leboulch (France)(30 mins)
8.2) Vector development
Philppe Leboulch (France)(30 mins)
8.3) Gene therapy in Wiskott Aldrich syndrome
Nipan Israsena(Thailand)(30 mins)
17.00-17.10 / Closing